NCT06891196View on ClinicalTrials.gov

Mixed-Methods Evaluation of Short-, Medium-, and Long-Term Outcomes Following Hip Treatment

Active, not recruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

January 15, 2025

Primary Completion Date

January 15, 2026

Study Completion Date

January 15, 2026

Conditions
Hip DysplasiaLegg-Calvâe-Perthes DiseaseAvascular Necrosis of Hip
Interventions
OTHER

Long-term Follow-up Surveys

Patients will be given surveys, including validated PRO measures such as the Hip Disability and Osteoarthritis Outcomes Score (HOOS), Short-Form 12 (SF-12), Visual Analog Scale (VAS) for pain, and Marx activity scores.

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT06891196 - Mixed-Methods Evaluation of Short-, Medium-, and Long-Term Outcomes Following Hip Treatment | Biotech Hunter | Biotech Hunter